Check this!
Transradial approach for carotid artery stenting - A position paper from the Italian Society of Interventional Cardiology (SICI‐GISE)Transradial approach for carotid artery stenting: A position paper from the Italian Society of Interventional Cardiology (SICI-GISE)
Reply letter to Piccoleto II : seeking an appropriate primary endpoint for DCB clinical trials
Is Paclitaxel-Eluting Stent Use Justified by an Adequate Risk Profile?
Check my new article about Paclitaxel-Eluting Stent written through collaboration with dr. Farhat Fouladvant.
Is Paclitaxel-Eluting Stent Use Justified by an Adequate Risk Profile
EASTBOURNE registry finished the enrollment
EASTBOURNE
EASTBOURNE registry finished the enrollment a few days ago, with the terrific number of 2100 patients reached: this is the largest coronary DCB study ever done.
EASTBOURNE is a prospective registry and will describe the immediate and long term performance of the novel Magic Touch sirolimus-coated balloon for any coronary application. Interesting, this is an investigator-driven study without bias or inferences from the industry.
I want to congratulate each investigator of the study and Prof Antonio Colombo, co-chairman of the study.
Top enrollers are: L. Testa, T. Heang, A. Ielasi, I. Bossi, R. Latini, L. Yan, I. Sanchez, D. Milazzo, G. Caiazzo, F. Tomai, G. Di Palma, S. Benincasa, M. Montorfano, A. Nuruddin, G. Stefanini, G. Seresini, R. Singh, G. Cacucci.
You can find the interim analysis publication (600 pts @1y.) here: https://pubmed.ncbi.nlm.nih.gov/32740442/
Stay tuned!
__________
Bernardo Cortese, MD FESC
PICCOLETO II published in JACC Int.
It is my privilege to announce that PICCOLETO II RCT has just been published in JACC Int, November 2020.
For the first time, a DCB (Elutax SV/Emperor) outperformed a new-gen DES in terms of angiographic endpoint, in the native vessel disease setting.
I am including here the PDF version of the paper for your reference.
j.jcin.2020.08.035https://www.jacc.org/doi/10.1016/j.jcin.2020.08.035